BeStock  

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2408Drug Manufacturers - Specialty & Generic
$16.97 +$0.35 (+2.11%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.00 +0.18%
Open$16.61
Prev close$16.62
Day range$16.53 – $17.04
Volume2.86M
Market cap$3.10B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$16.50-2.8% vs. price
  • Buy 83%
  • Hold 17%
Low $8.00Now $16.97Avg $16.50High $21.00

Recent rating changes

The last 20 actions on file set price targets from $8.00 to $21.00, averaging $13.22.

DateFirmRatingTarget
11 Nov 2026 Barclays BUY $18.00
9 Nov 2026 H.C. Wainwright BUY $18.00
6 Nov 2026 Craig-Hallum BUY $18.00
6 Nov 2026 H.C. Wainwright BUY $18.00
6 Nov 2026 Oppenheimer BUY $21.00
6 Oct 2026 Barclays BUY $14.00
29 Sep 2026 Craig-Hallum BUY $12.00
21 Sep 2026 H.C. Wainwright BUY $10.00
10 Sep 2026 Craig-Hallum BUY $12.00
10 Sep 2026 Piper Sandler HOLD $8.00
10 Sep 2026 Leerink Partners BUY $16.00
10 Sep 2026 H.C. Wainwright BUY $10.00
20 Aug 2026 Barclays BUY $12.00
7 Aug 2026 Piper Sandler HOLD $8.00
7 Aug 2026 H.C. Wainwright BUY $10.00
8 Jul 2026 Craig-Hallum BUY $12.00
30 Jun 2026 Craig-Hallum BUY –
11 Jun 2026 Craig-Hallum BUY –
13 May 2026 Barclays BUY $9.00
8 May 2026 Craig-Hallum BUY $12.00

Discussion

No comments yet — be the first to weigh in on XERS.

Sign in to join the discussion.

Scroll to Top